Ocular surface squamous neoplasia with 360° limbal involvement: a study of 130 patients.


Journal

International ophthalmology
ISSN: 1573-2630
Titre abrégé: Int Ophthalmol
Pays: Netherlands
ID NLM: 7904294

Informations de publication

Date de publication:
Feb 2023
Historique:
received: 17 03 2022
accepted: 03 08 2022
pubmed: 12 8 2022
medline: 3 3 2023
entrez: 11 8 2022
Statut: ppublish

Résumé

To describe the risk factors, clinical features and management outcomes of ocular surface squamous neoplasia (OSSN) with 360° of limbal involvement (360-OSSN) and compare with segmental limbal involvement (SL-OSSN). Retrospective comparative study of 360-OSSN vs SL-OSSN. All 360-OSSN and every 10th patient with SL-OSSN during the study period (2012-2020) were included. Lesions with uncertain diagnosis were excluded. Of 1250 patients diagnosed with OSSN during the study period, 30 (2%) had 360-OSSN. A total of 100 patients of OSSN with SL-OSSN were included for comparison. 360-OSSN patients more often had longer duration of symptoms (mean, 17 vs 8 months; p, 0.003), prior misdiagnosis (17% vs 6%, p, 0.13) and prior intervention (47% vs 13%; p, 0.0002) than patients with SL-OSSN. 360-OSSN had higher incidence of scleral fixity (57% vs 16%; p < 0.0001), corneal/scleral melt (17% vs 0%; p, 0.0005), intraocular tumor extension (17% vs 0%; p, 0.003), orbital tumor extension (33% vs 1%; p < 0.0001), and advanced T stage at presentation (Tis: 37% vs 76%, T1: 0% vs 15%; T2: 7% vs 4%; T3: 27% vs 4%; T4: 30% vs 1%; p < 0.001). Over a mean follow-up of 14 months, lymph node metastasis (8% vs 0%; p, 0.05) and distant metastasis (4% vs 0%; p, 0.23) were more common in 360-OSSN group compared to SL-OSSN group. Risk factors of 360-OSSN include prolonged symptoms, prior misdiagnosis and prior intervention. It represents an advanced form of disease with propensity for corneo-scleral melt and invasive disease which requires aggressive management.

Identifiants

pubmed: 35951148
doi: 10.1007/s10792-022-02463-7
pii: 10.1007/s10792-022-02463-7
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

609-618

Informations de copyright

© 2022. The Author(s), under exclusive licence to Springer Nature B.V.

Références

Gichuhi S, Macharia E, Kabiru J et al (2015) Clinical presentation of ocular surface squamous neoplasia in Kenya. JAMA Ophthalmol 133(11):1305–1313
doi: 10.1001/jamaophthalmol.2015.3335 pubmed: 26378395 pmcid: 5321496
Zarei-Ghanavati S, Alizadeh R, Deng SX (2014) Topical interferon alpha-2b for treatment of noninvasive ocular surface squamous neoplasia with 360° limbal involvement. J Ophthalmic Vis Res 9(4):423–426
doi: 10.4103/2008-322X.150811 pubmed: 25709765 pmcid: 4329700
Kalamkar C, Radke N, Mukherjee A, Radke S (2016) Xeroderma pigmentosum with bilateral ocular surface squamous neoplasia and review of the literature. BMJ Case Rep. bcr2016215364.
Kumar DA, Agarwal A (2018) Giant ocular surface squamous neoplasia wrapping whole cornea. Eye Contact Lens 44:S358–S360
doi: 10.1097/ICL.0000000000000391 pubmed: 28557835
Patel H, Jeang LJ, Shah A, Espana EM, Margo CE (2018) Widespread ocular surface squamous neoplasia treated with topical interferon alpha-2b. Ocul Oncol Pathol 4(5):298–303
doi: 10.1159/000486339 pubmed: 30320101 pmcid: 6167668
Mohamed-Noriega K, Treviño-Herrera AB, Olvera-Barrios A, Morales-Wong F, Mohamed-Hamsho J (2019) Resolution of giant ocular surface squamous neoplasia with topical 5-fuorouracil 1. SAGE Open Med Case Rep. 2019 7:2050313X19843392
Cicinelli MV, Marchese A, Bandello F, Modorati G (2018) Clinical management of ocular surface squamous neoplasia: a review of the current evidence. Ophthalmol Ther 7(2):247–262
doi: 10.1007/s40123-018-0140-z pubmed: 30030703 pmcid: 6258579
Nanji AA, Sayyad FE, Galor A et al (2015) High-resolution optical coherence tomography as an adjunctive tool in the diagnosis of corneal and conjunctival pathology. Ocul Surf 13:226–235
doi: 10.1016/j.jtos.2015.02.001 pubmed: 26045235 pmcid: 4498969
Conway RM, Graue GF, Pelayes DE et al (2017) Conjunctival Carcinoma. American Joint Committee on Cancer (AJCC). AJCC Cancer Staging Manual, 8th edn. Springer, New York
Kapoor AG, Vempuluru VS, Laghimshetty S et al (2021) Ocular surface squamous neoplasia with coexistent microbial keratitis: incidence, risk factors, clinical features, microbiological profile, and treatment outcome. Cornea. https://doi.org/10.1097/ICO.0000000000002809
doi: 10.1097/ICO.0000000000002809
Kaliki S, Mohammad FA, Tahiliani P, Sangwan VS (2017) Concomitant simple limbal epithelial transplantation after surgical excision of ocular surface squamous neoplasia. Am J Ophthalmol 174:68–75
doi: 10.1016/j.ajo.2016.10.021 pubmed: 27832940

Auteurs

Vijitha S Vempuluru (VS)

Operation Eyesight Universal Institute for Eye Cancer, LV Prasad Eye Institute, Hyderabad, 500034, India.

Neha Ghose (N)

Operation Eyesight Universal Institute for Eye Cancer, LV Prasad Eye Institute, Hyderabad, 500034, India.

Monalisha Pattnaik (M)

Operation Eyesight Universal Institute for Eye Cancer, LV Prasad Eye Institute, Hyderabad, 500034, India.

Ashik Mohamed (A)

Ophthalmic Biophysics Laboratory, LV Prasad Eye Institute, Hyderabad, India.

Swathi Kaliki (S)

Operation Eyesight Universal Institute for Eye Cancer, LV Prasad Eye Institute, Hyderabad, 500034, India. kalikiswathi@yahoo.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH